Polymorphic and Expressional Analysis of Genes <i>CDKN2B</i> and <i>ADIPOQ</i> in Cardiovascular Patients Using Conventional and qPCR Approach

<b>Background:</b> In the modern age, the problem of heart disease is increasing day by day which cause even more deaths than cancer. The study was designed to evaluate the polymorphism and expressional analysis of genes <i>CDKN2B</i> and <i>ADIPOQ</i> in cardiovascular patients. <b>Methodology:</b> Blood samples of 300 cardiovascular patients and 300 controls were collected from Gannan and other hospitals of Pakistan. For polymorphism analysis, DNA was extracted followed, by conventional PCR to amplify the variants rs4977574, rs2383206, and rs2241766 of genes CDKN2B and ADIPOQ, respectively. For expressional analysis, mRNA was extracted from whole blood and converted into cDNA, followed by qPCR. <b>Results:</b> The results show that heterozygous (AG) of rs4977574 of the <i>CDKN2B</i> gene showed highly significant association with 2-folds increased risk of cardiovascular disease (CVD) (OR = 2.03; 95% Cl = 1.26-3.25; <i>p</i> < 0.0033) while heterozygous (AG) of rs2383206 of the gene <i>CDKN2B</i> exhibited significant association but with decreased risk of CVD (OR = 0.47; 95% Cl = 0.29-0.75; <i>p</i> < 0.0017). The results of <i>ADIPOQ</i> polymorphism rs2241766 show that the heterozygous genotype (TG) showed a significant association with a decreased risk of CVD (OR = 0.63; 95% CI = 0.39-1.01; <i>p</i> < 0.05) while the homozygous mutant genotype (GG) of rs2241766 again showed a highly significant association with CVD which increased the risk of CVD by 2-folds (OR = 1.77; 95% CI = 1.11-2.80; <i>p</i> < 0.0150). The results of expressional analysis show that <i>CDKN2B</i> is significantly overexpressed in cardiovascular patients, while the gene <i>ADIPOQ</i> showed significant downregulation. <b>Conclusion:</b> The findings show that the <i>CDKN2B</i> and <i>ADIPOQ</i> gene polymorphisms significantly raise the risk for CVD, while their expression shows a significant correlation with CVD.

Authors

Institutions

Publication Details

Journal
International Journal of Hypertension
Published
2025-01-01
DOI
https://doi.org/10.1155/ijhy/7379376
Primary Topic
Cardiovascular Health and Risk Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polymorphic and Expressional Analysis of Genes CDKN2B and ADIPOQ in Cardiovascular Patients Using Conventional and qPCR Approach

Kashif Bashir, Muhammad Umar, Tooba Ashraf, Sana Zahra et al.
International Journal of Hypertension
Cardiovascular Health and Risk Factors
article

Polymorphic and Expressional Analysis of Genes CDKN2B and ADIPOQ in Cardiovascular Patients Using Conventional and qPCR Approach

Kashif Bashir, Muhammad Umar, Tooba Ashraf, Sana Zahra, Sayeda Fatima Tuba Sidra Batool, Hanan Nasir
article en

Abstract

<b>Background:</b> In the modern age, the problem of heart disease is increasing day by day which cause even more deaths than cancer. The study was designed to evaluate the polymorphism and expressional analysis of genes <i>CDKN2B</i> and <i>ADIPOQ</i> in cardiovascular patients. <b>Methodology:</b> Blood samples of 300 cardiovascular patients and 300 controls were collected from Gannan and other hospitals of Pakistan. For polymorphism analysis, DNA was extracted followed, by conventional PCR to amplify the variants rs4977574, rs2383206, and rs2241766 of genes CDKN2B and ADIPOQ, respectively. For expressional analysis, mRNA was extracted from whole blood and converted into cDNA, followed by qPCR. <b>Results:</b> The results show that heterozygous (AG) of rs4977574 of the <i>CDKN2B</i> gene showed highly significant association with 2-folds increased risk of cardiovascular disease (CVD) (OR = 2.03; 95% Cl = 1.26-3.25; <i>p</i> < 0.0033) while heterozygous (AG) of rs2383206 of the gene <i>CDKN2B</i> exhibited significant association but with decreased risk of CVD (OR = 0.47; 95% Cl = 0.29-0.75; <i>p</i> < 0.0017). The results of <i>ADIPOQ</i> polymorphism rs2241766 show that the heterozygous genotype (TG) showed a significant association with a decreased risk of CVD (OR = 0.63; 95% CI = 0.39-1.01; <i>p</i> < 0.05) while the homozygous mutant genotype (GG) of rs2241766 again showed a highly significant association with CVD which increased the risk of CVD by 2-folds (OR = 1.77; 95% CI = 1.11-2.80; <i>p</i> < 0.0150). The results of expressional analysis show that <i>CDKN2B</i> is significantly overexpressed in cardiovascular patients, while the gene <i>ADIPOQ</i> showed significant downregulation. <b>Conclusion:</b> The findings show that the <i>CDKN2B</i> and <i>ADIPOQ</i> gene polymorphisms significantly raise the risk for CVD, while their expression shows a significant correlation with CVD.

International Journal of HypertensionVol. 2025(1)
Superior University (PK)
Openalex Percentile: Top 65%
Cardiovascular Health and Risk Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.